btsnavbar.jpg


Ex Vivo Metrics™: How Drug Studies in Reanimated Human Organs Could Revitalize the Drug Development Process

An editorial by Gerald Curtis, PhD

Fallout from the catastrophic phase I clinical trial of TeGenero’s monoclonal antibody TGN1412 in March 2006,1 in which 6 volunteers suffered life-threatening “cytokine storms,” includes newly tightened regulations in the United Kingdom and renewed concern worldwide about first-in-human trials, particularly for compounds with novel targets or mechanisms of action. 

Read more  -  More Editorials

DNA Genotyping from human FFPE Samples

In this feasibility study, Applied Biosystems demonstrates how the combined 
use Recover All Total Nucleic

Acid Isolation Kit and TaqMan SNP Genotyping 
Assay can result in high quality, reproducible, and reliable genotyping 
data..  Read more
Millipore has launched the CellCiphr Cytotoxicity Profiling Assay Kit using human HepG2 cells. This assay panel detects drug-induced hepatotoxicity and is expected to be used early in the drug discovery process. read more

Cartesian Gridspeed, Ltd. announced the opening of its new sales, marketing and technical support subsidiary, SLIM Search, Inc. in Mission Viejo, California.
  SLIM Search, Inc. is marketing its SLIM Search genomic search tool to universities, government research, and research and development departments of biotechnology corporations and individual contributors. read more

The new Variant Reporter Software from Applied Biosystems automates detection of variants and streamlines data analysis process. The software uses proprietary algorithms to identify genetic variations based on standardized or user-defined parameters. Results are presented for validation in a visual format that allows researchers to simultaneously compare multiple quality control metrics. More information and a free trial version are available at: read more

More Products

We invite your comments and feedback for this edition of Biomarker Breakthroughs. Email us at maloryea@gmail.com
 

 

 

 

 

 

 

 

 

 

 

 

 

IN THIS ISSUE - STRATEGY

Molecular Toxicology: Bridging Animal and Human Studies
Pam Contag, Ph.D., Bio Imaging Founder and Executive, New Ventures, Caliper Life Sciences  Read more

NEWS BRIEFS

Compugen and Mayo Clinic are collaborating on a search for novel biomarkers to diagnose unstable atherosclerotic plaques. Read
Researchers have made preliminary findings of a distinct miRNA expression pattern that may differentiate pancreatic cancer from normal pancreas and chronic pancreatitis. Read
A small but increasing number of biotech companies are setting up within the San Francisco city limits, drawn by the ease of transportation and proximity to UCSF. Read
The American Cancer Society is recruiting half a million volunteers for a 20-year study to identify factors contributing to cancer risk. The Cancer Prevention Study 3, or CPS-3, will include cancer-free men and women between ages 30 and 60, who will contribute blood samples and fill out questionnaires. Read

CALENDAR

Biomarker World Congress 2007, May 15–17, Philadelphia, PA 
Trends in Pharmaceutical Development
World Pharmaceutical Congress, June 12–13, Philadelphia, PA 
Dedicated to All Areas of Biomarker Research Spanning the Pharmaceutical and Diagnostic Pipeline

Beyond Genome 2007, June 20–22, San Francisco, CA 
Top Ten Challenges in the Post-Genome Era

Thermo Fisher EI/CI Interpretation Module, July 31–August 2, West Palm Beach, FL This comprehensive course, by the Thermo Fisher Scientific Training Institute, will introduce the underlying principles of "classical" mass spectrometry and more. 

Basic Gas Chromatography, August 21–22 or October 23–24, West Palm Beach, FL 
Designed for those with little to no chromatography experience, this course is the perfect starting place for those who want to explore the key fundamentals and components associated with gas chromatography.

 



New - Yihan Wang of ARIAD Pharmaceuticals, Inc.

Neil W Gibson of OSI Pharmaceuticals

Jeffrey Settleman Harvard Medical School and MGH Cancer Center

David Bailey of Chemoventures

N Claude Cohen of Synergix

-View All Webcasts

     
Cambridge Healthtech Institute 2007 - Your Life Science Network 
Cambridge Healthtech Institute | 250 First Avenue | Suite 300 | Needham, MA 02494 Phone: 781-972-5400 | Fax: 781-972-5425 | chi@healthtech.com